{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":3,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"20b49a8bc553","filters":{"venue":"The Women s Oncology Review"}},"results":[{"id":"W1995028358","doi":"10.1080/14733400500136467","title":"Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial","year":2005,"lang":"en","type":"article","venue":"The Women s Oncology Review","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Randomized controlled trial; Breast cancer; Oncology; Chemotherapy; Internal medicine; Adjuvant chemotherapy; Adjuvant; Adjuvant radiotherapy; Cancer","authors":[{"name":"Thomas A. Buchholz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00537213899906246,"gpt":0.2413558783577223,"spread":0.2359837393586598,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00205498,0.0007970132,0.002943213,0.0002853032,0.0005086125,0.00103425,0.00084783,0.001435359,0.00455345],"category_scores_gemma":[0.003553583,0.0004042384,0.001712481,0.0008076968,0.0006832334,0.0004311325,0.0003261785,0.002504913,0.0005979044],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002470403,"about_ca_system_score_gemma":0.003389981,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0934541,"about_ca_topic_score_gemma":0.2215885,"domain_scores_codex":[0.998938,0.0006747452,0.00004668195,0.0001114205,0.00009880618,0.000130342],"domain_scores_gemma":[0.998195,0.0007478968,0.0003722748,0.0001308244,0.0002136156,0.000340427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9272104,0.001203486,0.007579432,0.002672012,0.005354332,0.0001292808,0.0001042961,0.0007771106,0.001665178,0.0001969779,0.008232563,0.04487502],"study_design_scores_gemma":[0.9156315,0.01478306,0.04832117,0.0006625917,0.01431938,0.00009723355,0.0001394702,0.0007929087,0.0004133997,0.0003573928,0.004417204,0.00006473465],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9191396,0.06078459,0.000519593,0.005903916,0.001122209,0.0009627067,0.002894907,0.0001192188,0.008553143],"genre_scores_gemma":[0.9668433,0.01832826,0.0005829047,0.003519116,0.0004541745,0.0005130203,0.001861777,0.00004150421,0.007855924],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9065459,"threshold_uncertainty_score":0.1858203,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3153436911","doi":"","title":"Screening and primary and secondary interventions for patients at high risk for ovarian cancer","year":2003,"lang":"en","type":"article","venue":"The Women s Oncology Review","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Ovarian cancer; Psychological intervention; Medicine; Oncology; Primary (astronomy); Internal medicine; Cancer; Gynecology; Psychiatry; Physics","authors":[{"name":"Noah A. Goldman","is_ca":false},{"name":"Antonella Restivo","is_ca":false},{"name":"Gary L. Goldberg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03752347636300222,"gpt":0.349505858240709,"spread":0.3119823818777067,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001130271,0.0003564009,0.001449365,0.001226175,0.000370266,0.0005931333,0.0005474245,0.001484969,0.005128121],"category_scores_gemma":[0.005507882,0.0002038137,0.000996088,0.001253631,0.0003093772,0.0006291191,0.000357312,0.001238054,0.0002556849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008926356,"about_ca_system_score_gemma":0.002371432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004224228,"about_ca_topic_score_gemma":0.01842898,"domain_scores_codex":[0.9991822,0.0004067519,0.00009372616,0.00006351393,0.0001756459,0.00007813643],"domain_scores_gemma":[0.9979633,0.001494641,0.0002015518,0.00002323065,0.0001546783,0.0001626775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001095783,0.000239393,0.007321632,0.02486308,0.0004767031,0.0007492233,0.0002775839,0.0001693909,0.0002924278,0.0008703108,0.03489668,0.9287478],"study_design_scores_gemma":[0.001805602,0.004675966,0.2314866,0.08035787,0.006596195,0.01963342,0.002195101,0.0003913453,0.0009533081,0.003024825,0.648758,0.0001217361],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002862038,0.9923901,0.00003727636,0.002272296,0.0005880658,0.00001460104,0.00001958572,0.000003495142,0.001812551],"genre_scores_gemma":[0.03224969,0.9626727,0.0002410635,0.002551534,0.001168635,0.00005389196,0.00006206169,0.000002396394,0.0009979779],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005128121,"threshold_uncertainty_score":0.01715523,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4243125367","doi":"10.3109/14733400410001728456","title":"Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19","year":2004,"lang":"en","type":"article","venue":"The Women s Oncology Review","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Doxorubicin; Breast cancer; Medicine; Metastatic breast cancer; Cancer; Internal medicine; Oncology; Chemotherapy","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.1757692435539034,"gpt":0.5063471901154966,"spread":0.3305779465615932,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001309228,0.0009011261,0.002064128,0.0003081955,0.0004439093,0.0006799825,0.001028221,0.00153178,0.004123483],"category_scores_gemma":[0.001073228,0.0004308328,0.001021235,0.0004777086,0.0005185092,0.0004383253,0.0002347816,0.001950557,0.0007099583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001634986,"about_ca_system_score_gemma":0.003674821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01397258,"about_ca_topic_score_gemma":0.0520656,"domain_scores_codex":[0.9996692,0.0001869759,0.00001416424,0.00003946066,0.00004200629,0.00004820015],"domain_scores_gemma":[0.999419,0.0001175451,0.0001378329,0.00002363865,0.00006672705,0.0002352608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6803095,0.02573724,0.004184774,0.0035653,0.004207522,0.0002942391,0.0002806881,0.001198685,0.03196641,0.0006626103,0.03369718,0.213896],"study_design_scores_gemma":[0.6733353,0.2780497,0.01500118,0.0003319611,0.002709587,0.0004298339,0.0001423321,0.0006286745,0.004086172,0.0003250627,0.02491758,0.00004251827],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8176389,0.1426167,0.001334399,0.006948743,0.001298209,0.006996834,0.005402108,0.000253131,0.01751104],"genre_scores_gemma":[0.8808652,0.07789951,0.00364708,0.006952432,0.0008676474,0.004705505,0.004956249,0.00007432753,0.02003203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01397258,"threshold_uncertainty_score":0.0277825,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}